login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Arqule (ARQL) Stock News
NASDAQ:ARQL - Nasdaq -
20
+0.03 (+0.15%)
After market: 19.99
-0.01 (-0.05%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ARQL Latest News, Press Relases and Analysis
All
Press Releases
6 years ago - By: The Motley Fool
These Were the 10 Best Stocks of 2019
6 years ago - By: The Motley Fool
- Mentions:
MRK
Why Biotech Stock ArQule Soared 108% in December
6 years ago - By: Marketwatch
- Mentions:
AMD
AAPL
MSFT
AMZN
...
Deep Dive: Here are the best-performing Nasdaq stocks of 2019
6 years ago - By: Marketwatch
- Mentions:
AMD
AAPL
MSFT
AMZN
...
The best performing Nasdaq stocks of 2019
6 years ago - By: Zacks Investment Research
- Mentions:
THOR
FATE
CGC
Company News for Dec 10, 2019
6 years ago - By: Marketwatch
- Mentions:
AMD
AAPL
MSFT
AMZN
...
Deep Dive: Here are the best-performing Nasdaq stocks of 2019
6 years ago - By: Halper Sadeh LLP
- Mentions:
THOR
LOGM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - THOR, ARQL, LOGM
6 years ago - By: Benzinga
- Mentions:
XBI
ACAD
ALNY
AMRN
...
A Perspective On Biopharma's Record M&A Run In 2019
6 years ago - By: Halper Sadeh LLP
- Mentions:
CRCM
TCBI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - CRCM, TCBI, ARQL
6 years ago - By: Seeking Alpha
- Mentions:
MRK
Merck begins tender offer to acquire Arqule
6 years ago - By: Benzinga
- Mentions:
XBI
IBB
THOR
MRK
...
The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week
6 years ago - By: Barron's
- Mentions:
BA
AMZN
SPCE
TSLA
...
Space Tourism Is Getting Closer. Here’s How Much It Will Cost.
6 years ago - By: Investor's Business Daily
- Mentions:
TSLA
FB
BA
AZO
...
Dow Jones Hits Record High On China Trade Deal; Lululemon, Adobe, Tesla, Facebook, Boeing, Chips, Biotechs Make News: Weekly Review
6 years ago - By: WeissLaw LLP
- Mentions:
MRK
SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.
6 years ago - By: Marketwatch
- Mentions:
MDCO
NVS
NOVN
SOBI
...
: There’s more upside for biotech even after 24% gains in two months
6 years ago - By: Investor's Business Daily
- Mentions:
PRNB
MRK
SNY
ABBV
Why Merck, Sanofi News Helped This Biotech Rocket 31% Over Two Days
6 years ago - By: Marketwatch
- Mentions:
NVS
GBT
BLUE
GILD
...
Investors shift attention to next generation of CAR-T, new sickle cell treatments at major hematology meeting
6 years ago - By: Zacks Investment Research
- Mentions:
MRK
SNY
NVS
THOR
...
Why Biotech ETFs are Surging to New Highs
6 years ago - By: Monteverde & Associates PC
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of ArQule, Inc - ARQL
6 years ago - By: Zacks Investment Research
- Mentions:
SNY
BMY
MRK
Merck to Buy ArQule for $2.7B to Boost Cancer Portfolio
Please enable JavaScript to continue using this application.
